These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 2575225

  • 21. Neuropathological evaluation by combined immunohistochemistry and degeneration-specific methods: application to methylenedioxymethamphetamine.
    Scallet AC, Lipe GW, Ali SF, Holson RR, Frith CH, Slikker W.
    Neurotoxicology; 1988; 9(3):529-37. PubMed ID: 2904668
    [Abstract] [Full Text] [Related]

  • 22. Effects of intracerebroventricular administration of 5-(glutathion-S-yl)-alpha-methyldopamine on brain dopamine, serotonin, and norepinephrine concentrations in male Sprague-Dawley rats.
    Miller RT, Lau SS, Monks TJ.
    Chem Res Toxicol; 1996 Mar; 9(2):457-65. PubMed ID: 8839050
    [Abstract] [Full Text] [Related]

  • 23. 3,4-Methylenedioxymethamphetamine, serotonin and memory.
    Ricaurte GA, Markowska AL, Wenk GL, Hatzidimitriou G, Wlos J, Olton DS.
    J Pharmacol Exp Ther; 1993 Aug; 266(2):1097-105. PubMed ID: 8102642
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Toxic effects of MDMA on central serotonergic neurons in the primate: importance of route and frequency of drug administration.
    Ricaurte GA, DeLanney LE, Irwin I, Langston JW.
    Brain Res; 1988 Apr 12; 446(1):165-8. PubMed ID: 2897228
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Reinforcing subjective effects of (+/-) 3,4-methylenedioxymethamphetamine ("ecstasy") may be separable from its neurotoxic actions: clinical evidence.
    McCann UD, Ricaurte GA.
    J Clin Psychopharmacol; 1993 Jun 12; 13(3):214-7. PubMed ID: 8102623
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Hallucinogenic amphetamine selectively destroys brain serotonin nerve terminals.
    Ricaurte G, Bryan G, Strauss L, Seiden L, Schuster C.
    Science; 1985 Sep 06; 229(4717):986-8. PubMed ID: 4023719
    [Abstract] [Full Text] [Related]

  • 31. 3,4-methylenedioxymethamphetamine (MDMA) administration to rats decreases brain tissue serotonin but not serotonin transporter protein and glial fibrillary acidic protein.
    Wang X, Baumann MH, Xu H, Rothman RB.
    Synapse; 2004 Sep 15; 53(4):240-8. PubMed ID: 15266556
    [Abstract] [Full Text] [Related]

  • 32. MDMA, methamphetamine and their combination: possible lessons for party drug users from recent preclinical research.
    Clemens KJ, McGregor IS, Hunt GE, Cornish JL.
    Drug Alcohol Rev; 2007 Jan 15; 26(1):9-15. PubMed ID: 17364831
    [Abstract] [Full Text] [Related]

  • 33. Evaluation of the neurotoxicity of N-methyl-1-(4-methoxyphenyl)-2-aminopropane (para-methoxymethamphetamine, PMMA).
    Steele TD, Katz JL, Ricaurte GA.
    Brain Res; 1992 Sep 04; 589(2):349-52. PubMed ID: 1382813
    [Abstract] [Full Text] [Related]

  • 34. A study of the neurotoxic effect of MDMA ('ecstasy') on 5-HT neurones in the brains of mothers and neonates following administration of the drug during pregnancy.
    Colado MI, O'Shea E, Granados R, Misra A, Murray TK, Green AR.
    Br J Pharmacol; 1997 Jun 04; 121(4):827-33. PubMed ID: 9208155
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Neurotoxic amphetamine analogues: effects in monkeys and implications for humans.
    Ricaurte GA, McCann UD.
    Ann N Y Acad Sci; 1992 May 11; 648():371-82. PubMed ID: 1379014
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Pharmacokinetic profile of single and repeated oral doses of MDMA in squirrel monkeys: relationship to lasting effects on brain serotonin neurons.
    Mechan A, Yuan J, Hatzidimitriou G, Irvine RJ, McCann UD, Ricaurte GA.
    Neuropsychopharmacology; 2006 Feb 11; 31(2):339-50. PubMed ID: 15999148
    [Abstract] [Full Text] [Related]

  • 39. Neurotoxic effects of the alpha-ethyl homologue of MDMA following subacute administration.
    Johnson MP, Nichols DE.
    Pharmacol Biochem Behav; 1989 May 11; 33(1):105-8. PubMed ID: 2476831
    [Abstract] [Full Text] [Related]

  • 40. The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy").
    Green AR, Mechan AO, Elliott JM, O'Shea E, Colado MI.
    Pharmacol Rev; 2003 Sep 11; 55(3):463-508. PubMed ID: 12869661
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.